“Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3 3b Trials”. 2026. SKIN The Journal of Cutaneous Medicine 10 (3): s772. https://doi.org/10.25251/pkdcct35.